703 related articles for article (PubMed ID: 23116337)
1. Intranasal drug delivery to the central nervous system: present status and future outlook.
Tayebati SK; Nwankwo IE; Amenta F
Curr Pharm Des; 2013; 19(3):510-26. PubMed ID: 23116337
[TBL] [Abstract][Full Text] [Related]
2. Intranasal delivery of biologics to the central nervous system.
Lochhead JJ; Thorne RG
Adv Drug Deliv Rev; 2012 May; 64(7):614-28. PubMed ID: 22119441
[TBL] [Abstract][Full Text] [Related]
3. Insights into direct nose to brain delivery: current status and future perspective.
Mittal D; Ali A; Md S; Baboota S; Sahni JK; Ali J
Drug Deliv; 2014 Mar; 21(2):75-86. PubMed ID: 24102636
[TBL] [Abstract][Full Text] [Related]
4. Applications of nanotechnology in drug delivery to the central nervous system.
Saeedi M; Eslamifar M; Khezri K; Dizaj SM
Biomed Pharmacother; 2019 Mar; 111():666-675. PubMed ID: 30611991
[TBL] [Abstract][Full Text] [Related]
5. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
Begley DJ
Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
[TBL] [Abstract][Full Text] [Related]
6. Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair.
Sharma A; Menon P; Muresanu DF; Ozkizilcik A; Tian ZR; Lafuente JV; Sharma HS
CNS Neurol Disord Drug Targets; 2016; 15(9):1092-1117. PubMed ID: 27538949
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnological advances for the delivery of CNS therapeutics.
Wong HL; Wu XY; Bendayan R
Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
[TBL] [Abstract][Full Text] [Related]
8. From naturally-occurring neurotoxic agents to CNS shuttles for drug delivery.
Soddu E; Rassu G; Giunchedi P; Sarmento B; Gavini E
Eur J Pharm Sci; 2015 Jul; 74():63-76. PubMed ID: 25892455
[TBL] [Abstract][Full Text] [Related]
9. Mathematical Modeling and Simulation to Investigate the CNS Transport Characteristics of Nanoemulsion-Based Drug Delivery Following Intranasal Administration.
Kadakia E; Bottino D; Amiji M
Pharm Res; 2019 Mar; 36(5):75. PubMed ID: 30923914
[TBL] [Abstract][Full Text] [Related]
10. Intranasal delivery to the central nervous system: mechanisms and experimental considerations.
Dhuria SV; Hanson LR; Frey WH
J Pharm Sci; 2010 Apr; 99(4):1654-73. PubMed ID: 19877171
[TBL] [Abstract][Full Text] [Related]
11. Differential receptor-mediated drug targeting to the diseased brain.
Rip J; Schenk GJ; de Boer AG
Expert Opin Drug Deliv; 2009 Mar; 6(3):227-37. PubMed ID: 19327042
[TBL] [Abstract][Full Text] [Related]
12. Targeting specific cells in the brain with nanomedicines for CNS therapies.
Zhang F; Lin YA; Kannan S; Kannan RM
J Control Release; 2016 Oct; 240():212-226. PubMed ID: 26686078
[TBL] [Abstract][Full Text] [Related]
13. Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders.
Govender T; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Modi G; Naidoo D; Pillay V
Pharm Dev Technol; 2017 Jun; 22(4):476-486. PubMed ID: 27268737
[TBL] [Abstract][Full Text] [Related]
14. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
Kanazawa T
Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of intranasal delivery route of drug administration for brain targeting.
Erdő F; Bors LA; Farkas D; Bajza Á; Gizurarson S
Brain Res Bull; 2018 Oct; 143():155-170. PubMed ID: 30449731
[TBL] [Abstract][Full Text] [Related]
16. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.
Goyal K; Koul V; Singh Y; Anand A
Cent Nerv Syst Agents Med Chem; 2014; 14(1):43-59. PubMed ID: 25360772
[TBL] [Abstract][Full Text] [Related]
17. Formulation and physiological factors influencing CNS delivery upon intranasal administration.
Vyas TK; Tiwari SB; Amiji MM
Crit Rev Ther Drug Carrier Syst; 2006; 23(4):319-47. PubMed ID: 17341201
[TBL] [Abstract][Full Text] [Related]
18. Prodrug approaches to reduce hyperexcitation in the CNS.
Vytla D; Combs-Bachmann RE; Hussey AM; McCarron ST; McCarthy DS; Chambers JJ
Adv Drug Deliv Rev; 2012 May; 64(7):666-85. PubMed ID: 22138074
[TBL] [Abstract][Full Text] [Related]
19. Polymeric nanoparticles for drug delivery to the central nervous system.
Patel T; Zhou J; Piepmeier JM; Saltzman WM
Adv Drug Deliv Rev; 2012 May; 64(7):701-5. PubMed ID: 22210134
[TBL] [Abstract][Full Text] [Related]
20. Numerical Comparison of Nasal Aerosol Administration Systems for Efficient Nose-to-Brain Drug Delivery.
Dong J; Shang Y; Inthavong K; Chan HK; Tu J
Pharm Res; 2017 Dec; 35(1):5. PubMed ID: 29288465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
